This invention relates to natural ligands of NKp46 and compositions and methods for modulating NK-cell activation through NKp46 receptors. The compositions and methods can be used, in particular, for the treatment and diagnosis of disease in humans, for example cancers, infectious disease and inflammatory or autoimmune diseases.
展开▼
